THYSAT

This brand name is authorized in United Kingdom

Active ingredients

The drug THYSAT contains one active pharmaceutical ingredient (API):

1 Potassium iodide UNII 1C4QK22F9J - POTASSIUM IODIDE

Potassium iodide is indicated as a thyroid-blocking agent to prevent the uptake of radioactive iodine, for example after a nuclear accident or during a nuclear medicine investigation before administering a radioiodinated compound, which is metabolised to iodide or which contains radioiodine impurities. Read about Potassium iodide

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
THYSAT Tablet	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
V03AB21	Potassium iodide	V Various → V03 All other therapeutic products → V03A All other therapeutic products → V03AB Antidotes
Discover more medicines within V03AB21

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 223229, 223230, 365281